Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Type 2 diabetes as a related topic and included MedlinePlus Genetics as related topics. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check23 days agoChange DetectedRemoved related topics tags: 'Type 2 diabetes' and 'MedlinePlus Genetics' from the study page.SummaryDifference0.2%

- Check30 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows Revision: v3.4.2; the prior government-funding lapse notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check65 days agoChange DetectedNotice: Added a government funding lapse banner and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded a 'Show glossary' option and updated footer labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with the site revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.